Search
for
Sort by
Research 301–330 of 1000+
- Topical minoxidil. A survey of use and complications
- Chronic Treatment with Minoxidil Induces Elastic Fiber Neosynthesis and Functional Improvement in the Aorta of Aged Mice
- Mycophenolate Antagonizes IFN-γ-Induced Catagen-Like Changes via β-Catenin Activation in Human Dermal Papilla Cells and Hair Follicles
- Topical Minoxidil
- Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial
- Effect of minoxidil on blood pressure and hemodynamics in severe hypertension
- Bioavailability assessment of topical delivery systems: Effect of vehicle evaporation upon in vitro delivery of minoxidil from solution formulations
- Stem cell apoptosis in HIV‐1 alopecia
- Pharmacokinetic studies of minoxidil
- Reversal of Baldness in Patient Receiving Minoxidil for Hypertension
- Effect of ultraviolet light on topical minoxidil-induced hair growth in advanced male pattern baldness
- Comparison of the effects of the K+-channel openers cromakalim and minoxidil sulphate on vascular smooth muscle
- Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- The use of topical minoxidil to accelerate nail growth: a pilot study
- TOPICAL MINOXIDIL THERAPY FOR ANDROGENIC ALOPECIA IN THE MIDDLE EAST
- In vivo hair re-growth efficacies of minoxidil preparations: distearyldimethylammonium chloride vesicles, cellulose acetate phthalate microparticles, and poloxamer solution
- Comparative efficacy of oral dutasteride and low-, medium-, and high-dose oral minoxidil: a six-month prospective trichoscopic and clinical study
- Preparation and evaluation of minoxidil nanoemulgel topical formulations.
- Relative Influence of Ethanol and Propylene Glycol Cosolvents on Deposition of Minoxidil into the Skin
- Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women
- A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Insulin Promotes Corneal Nerve Repair and Wound Healing in Type 1 Diabetic Mice by Enhancing Wnt/β-Catenin Signaling
- Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis
- Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): Three- and 4-year results
- A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
- Prostaglandin-Induced Hair Growth